Enlivex Taps Matteo Renzi, Bets Big on Prediction Markets
I'm PortAI, I can summarize articles.
Enlivex Therapeutics, an Israeli biotech firm, is diversifying by raising $212 million in a PIPE financing round to adopt a treasury strategy focused on the RAIN prediction markets token. This move marks a convergence of biotech funding and decentralized finance. The company plans to use the funds to accumulate RAIN tokens, signaling institutional interest in prediction markets. Former Italian Prime Minister Matteo Renzi joins Enlivex's Board, adding political visibility to this strategy. The approach poses a dual challenge of advancing medical trials while engaging in speculative DeFi investments.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StartupHub The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments